Beatriz M Carreno

6PUBLICATIONS
54CO-AUTHORS
Molecular targetsGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 27, 2026
Therapeutic scheduling of WEE1 inhibition preserves T cell function and promotes immune control of HPV+ tumors.

Ying Liu, Zhiheng Zhang, Yanshan Tao

|Jan 24, 2024
Facts and Hopes in Immunotherapy Strategies Targeting Antigens Derived from KRAS Mutations.

Gerald P Linette, Adham S Bear, Beatriz M Carreno

|Nov 22, 2022
Anti-BCMA/CD19 CAR T Cells with Early Immunomodulatory Maintenance for Multiple Myeloma Responding to Initial or Later-Line Therapy.

Alfred L Garfall, Adam D Cohen, Sandra P Susanibar-Adaniya

|Mar 15, 2022
On the Twentieth Anniversary of Dendritic Cell Vaccines - Riding the Next Wave.

Gerald P Linette, Beatriz M Carreno

|Jul 17, 2021
Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting.

Adham S Bear, Tatiana Blanchard, Joseph Cesare

Pageof 1